SPIB and lung cancer: In another study, Zhang et al. [48] demonstrated that SPIB is an essential TF that elevates the expression of SNAP47 in lung cancer, leading to enhanced autophagy-mediated anoikis resistance, suggesting that SPIB can be considered as a potential drug target for the prevention and therapeutic procedures of metastatic lung cancers.